Tags: Drug.

Deleobuvir (formerly BI 207127) was an experimental drug for the treatment of hepatitis C. It was being developed by Boehringer-Ingelheim. It is a non-nucleoside hepatitis C virus NS5B polymerase inhibitor.

Deleobuvir.svg
ATC prefix
None
CAS number
1221574-24-8
IUPAC name
(2E)-3-(2-1-[2-(5-Bromopyrimidin-2-yl)-3-cyclopentyl-1-methyl-1H-indole-6-carboxamido]cyclobutyl-1-methyl-1H-benzimidazol- 6-yl)prop-2-enoic acid

Loading...

This page contains content from the copyrighted Wikipedia article "Deleobuvir"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.